INNATE PHARMA

IPH
Real-time Quote. Real-time  - 10/18 10:28:18 am
4.888EUR -4.16%

Turn to zoom
Prev.5.1000
Open5.0500
High5.1100
Low4.8200
Volume598 124
Latest news
09/28
09/20
09/20
09/17
Chart INNATE PHARMA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance7,007,007,00
Spread/Res.-30%-30%-30%
Spread/Supp.14%14%11%
Support4,304,304,41
Financials
Sales 2021 40,9 M 47,5 M 47,5 M
Net income 2021 -44,6 M -51,7 M -51,7 M
Net cash 2021 79,8 M 92,6 M 92,6 M
P/E ratio 2021 -8,03x
Yield 2021 -
Capitalization 404 M 469 M 469 M
EV / Sales 2021 7,93x
EV / Sales 2022 7,28x
Nbr of Employees 212
Free-Float 75,2%
Company
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-16 Sales and Revenue Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 5,10 €
Average target price 7,77 €
Spread / Average Target 52,3%